Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.
暂无分享,去创建一个
P. Validire | H. Magdelenat | E. Stanley | P. Pouillart | V. Mosseri | S. Scholl | T. Dorval | S. M. Scholl | C. H. Bascou | V. Mosseri | R. Olivares | H. Magdelenat | T. Dorval | T. Palangié | P. Validire | P. Pouillart | E. R. Stanley | T. Palangié | R. Olivares | C. Bascou | Pierre Pouillart | Henri Magdelenat | Pierre Validire | Thierry Dorval | Thao Palangié
[1] O. Kallioniemi,et al. Prognostic significance of dna index, multiploidy, and S‐phase fraction in ovarian cancer , 1988, Cancer.
[2] J. Pollard,et al. Regulation of colony-stimulating factor 1 during pregnancy , 1986, The Journal of experimental medicine.
[3] M. McKay,et al. Cancer of the ovary. , 1994, The New England journal of medicine.
[4] P. Schwartz,et al. Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms. , 1989, International journal of radiation oncology, biology, physics.
[5] V. Praloran. Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF-1 or M-CSF). , 1991, Nouvelle revue francaise d'hematologie.
[6] B. Cocks,et al. Activation and proliferation signals in murine macrophages. Biochemical signals controlling the regulation of macrophage urokinase-type plasminogen activator activity by colony-stimulating factors and other agents. , 1991, Blood.
[7] R. Bast,et al. Tissue Distribution of a Coelomic- Epithelium‐Related Antigen Recognized by the Monoclonal Antibody OC125 , 1983, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[8] B. Gullberg,et al. Prognostic factors in malignant epithelial ovarian tumors. , 1983, Gynecologic oncology.
[9] E. Stanley,et al. Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells , 1980, Journal of Cell Biology.
[10] J. Horiguchi,et al. CSF-1 and C-FMS gene expression in human carcinoma cell lines. , 1988, Biochemical and biophysical research communications.
[11] A. Wolkoff,et al. Macrophages specifically regulate the concentration of their own growth factor in the circulation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Hawkins,et al. The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma. , 1989, British Journal of Cancer.
[13] E. Stanley. Colony-stimulating factor (CSF) radioimmunoassay: detection of a CSF subclass stimulating macrophage production. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[14] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[15] E. Stanley,et al. The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages. , 1986, The Journal of biological chemistry.
[16] C. Redman,et al. Peritoneal trauma releases CA125? , 1988, British Journal of Cancer.
[17] R. Bast,et al. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. , 1989, The Journal of clinical investigation.
[18] H. Egami,et al. Evaluation of Serum CA125 Values in Healthy Individuals and Pregnant Women , 1986, The American journal of the medical sciences.
[19] F. Beuvon,et al. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: A role for hematopoietic growth factor release by tumor cells? , 1990, Journal of cellular biochemistry.
[20] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[21] E. Stanley,et al. Purification of the colony-stimulating factor 1 receptor and demonstration of its tyrosine kinase activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[22] Robert A. Edwards,et al. High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. , 1988, International journal of radiation oncology, biology, physics.
[23] R. Arceci,et al. Apparent role of the macrophage growth factor, CSF-1, in placental development , 1987, Nature.
[24] V. Praloran,et al. Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension. , 1989, Blood.
[25] P. Tynan,et al. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy , 1982, Cell.
[26] L. Yee,et al. Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. , 1990, The American journal of pathology.
[27] A. Belch,et al. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. , 1991, Blood.
[28] A. Mantovani,et al. Induction of monocyte migration by recombinant macrophage colony-stimulating factor. , 1988, Journal of immunology.
[29] R. Bast,et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.
[30] D.,et al. Regression Models and Life-Tables , 2022 .